Norden Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Norden Group's BIIB Position: Q3 2026 in Review
Norden Group reduced its Biogen (BIIB) stake by 0.74% in Q3 2026, selling an estimated $1.48K and leaving 938 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #626.
Norden Group first reported a position in BIIB in Q3 2023 and has held it in 7 quarters since. The position peaked at $552K in Q3 2023. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Norden Group held 938 shares of Biogen worth $212K as of Q3 2026.
- Norden Group sold 7 Biogen shares in Q3 2026, an estimated $1.48K.
- Biogen made up 0.02% of Norden Group's portfolio in Q3 2026, its #626 holding.
- Norden Group first reported a position in Biogen in Q3 2023 and has held it in 7 quarters since.
- Norden Group's Biogen position peaked at $552K in Q3 2023.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.